de Vries T J, van Muijen G N, Ruiter D J
Department of Pathology, University Hospital, Nijmegen, The Netherlands.
Melanoma Res. 1996 Apr;6(2):79-88. doi: 10.1097/00008390-199604000-00001.
A large body of evidence suggests a role for the proteolytic plasminogen activation system in invasion and metastatic spread of tumor cells including melanoma cells. Plasminogen activation by human melanoma cell lines and B16 mouse melanoma cell lines has been extensively studied. Apart from expression of urokinase-type plasminogen activator, melanoma cells differ from cells derived from other tumors in the abundant expression of tissue-type plasminogen activator. The possible role of both types of plasminogen activator in metastatic spread of melanoma cells is discussed. In recent years the localization of mRNAs and proteins of the plasminogen activation system and of related proteins in cutaneous melanocytic tumor progression has been well documented. A possible mechanism for migration of melanoma cells in vivo is suggested.
大量证据表明,蛋白水解性纤溶酶原激活系统在包括黑色素瘤细胞在内的肿瘤细胞侵袭和转移扩散中发挥作用。人黑色素瘤细胞系和B16小鼠黑色素瘤细胞系对纤溶酶原的激活作用已得到广泛研究。除了尿激酶型纤溶酶原激活剂的表达外,黑色素瘤细胞与其他肿瘤来源的细胞不同,其组织型纤溶酶原激活剂表达丰富。本文讨论了这两种纤溶酶原激活剂在黑色素瘤细胞转移扩散中的可能作用。近年来,纤溶酶原激活系统的mRNA和蛋白质以及相关蛋白质在皮肤黑素细胞肿瘤进展中的定位已有充分记录。本文提出了黑色素瘤细胞在体内迁移的一种可能机制。